Replies to post #1550 on Cancer

[wow_happens28]

Scary Bob, geez. My local super value is offering 20% of of their next grocery purchase if you get a flu shot, OMG. I did not read the details and got to guess it might be on the first $20 or such. It must be quite profitable for them to offer that. What scares me that with national health care, it might be mandated for all seniors or lose you insurance and or social security. I hope Trump has some control over it, but Reagan disappointed me and I suspect Trump will too. If the NWO people were really against trump, he'd be dead or will be soon?

[wow_happens28]

I think we know the answer to the headline below Bob, sad

Why is the FDA Fast Tracking Squalene as a Flu Vaccine Ingredient for Seniors?

https://healthimpactnews.com/2015/why-is-the-fda-fast-tracking-squalene-as-a-flu-vaccine-ingredient-for-seniors/

NVIC Questions FDA Fast Tracking of Squalene Adjuvanted Flu Vaccine

by The Vaccine Reaction

The non-profit National Vaccine Information Center (NVIC) is questioning the basis for the fast tracked licensure by the U.S. Food and Drug Administration (FDA) of a squalene-adjuvanted influenza vaccine for use in seniors over age 65. The Novartis MF59 adjuvanted Fluad vaccine was approved for accelerated licensure by the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Sept. 15, 2015 primarily using limited immunogenicity and safety evidence from a small clinical trial in which only about 1,000 healthy Americans over age 65 were given the adjuvanted vaccine.1 2

“Novartis failed to demonstrate that squalene adjuvanted Fluad was more effective or safer than an unadjuvanted influenza vaccine in the small clinical trial being used to justify accelerated licensure. In fact, Fluad was shown to be far more reactive and, in some studies, the vaccine was associated with even more serious reactions in the elderly when given a second time,” said NVIC Co-founder and President Barbara Loe Fisher.

At public comment time, Fisher asked the FDA advisory committee, “Why does Fluad need to be fast tracked to licensure for the elderly without additional evidence? There is public concern that fast tracking Fluad is really about fast tracking MF59 to licensure so it can be added to lots of new vaccines targeting infants, pregnant women and every American without adequate evidence for safety or effectiveness.”3

Before the FDA advisory committee had taken a vote on whether Novartis had demonstrated the safety and effectiveness of Fluad in seniors, agency officials indicated they would approve accelerated licensure of the vaccine even though fast tracking is supposed to be reserved for instances when there are vaccine shortages. There are nine influenza vaccines licensed by the FDA as safe and effective for seniors, including two high dose options, and the Centers for Disease Control (CDC) estimates more than 170 million doses of influenza vaccine will be delivered to the U.S. market for the 2015-2016 flu season.4

Although MF59 is bioactive and designed to stimulate a strong immune response, FDA does not require that vaccine adjuvants be proven safe in a placebo controlled trial and they are not licensed separately.5 Fluad will be the first influenza vaccine licensed in the U.S. containing squalene, a controversial oil in water adjuvant that has been linked with development of autoimmunity, narcolepsy and other immune and neurological disorders.6

In her Sept. 15 public statement at the FDA advisory committee meeting, Fisher pointed out that the Novartis clinical trial did not provide sufficient evidence for fast track licensure of Fluad when:

It is known that responses to vaccination are affected by genetic factors and only 30 percent of the Fluad study population was ethnically representative of U.S. seniors over age 65;
The majority of Fluad study participants did not have heart, lung and kidney disease or other chronic health conditions that affect two-thirds of U.S. seniors, although chronically ill seniors will be recipients of Fluad after licensure;
Fluad produced a much higher number of pain, tenderness, redness and swelling reports; a higher number of systemic adverse reaction reports and more deaths and cases of new onset chronic disease;
The study did not evaluate the safety of giving repeated doses of squalene adjuvanted Fluad year after year to seniors with multiple chronic conditions;
There is no information on how Fluad performs when given simultaneously with other vaccines (such as pneumococcal vaccine).
NVIC is a charitable educational organization founded in 1982 to prevent vaccine injuries and deaths through public education. It does not make vaccine use recommendations and advocates for the inclusion of informed consent protections in U.S. vaccine policies and laws. NVIC monitors vaccine science, policy and law and provides public comment at federal vaccine advisory committee meetings.

Read the full article here.

[wow_happens28]

Diabetes drug shown to promote bladder cancer

http://www.naturalhealth365.com/bladder-cancer-big-pharma-2035.html

(NaturalHealth365) The drug pioglitazone, brand name Actos, is promoted as a substance to help control and regulate blood sugar – in people with type 2 diabetes. However, some of those people – that use this toxic drug – end up getting bladder cancer.
A study, published by The British Medical Journal (BMJ), has confirmed those taking the drug have a higher risk of bladder cancer among other Actos side effects. The findings also show that the risk of negative Actos side effects – like bladder cancer – gets higher with higher doses of the drug and the longer diabetes patients take it.
Bladder cancer warning: Actos side effects could be deadly
Pioglitazone is in a class of drugs called thiazolidinediones, which purport to help regulate blood sugar in those with type 2 diabetes. Rosiglitazone is another example of this type of drug; however, the bladder cancer risk did not seem to be associated with rosiglitazone, suggesting that the bladder cancer connection may not affect the entire thiazolidinedione class.
The connection between bladder cancer and Actos side effects was first detected unexpectedly in 2005. Persons taking the drug were being studied in a trial and were found to have a much higher incidence of bladder cancer compared with the study participants who were taking a placebo.
Recent research confirms bladder cancer among Actos side effects
However, these results and others like it had been considered “controversial,” as other studies since 2005 have reported differing results about the drug.
Because of the conflicting and contradicting information, a Canadian research team decided to test pioglitazone alongside other diabetes drugs. Data from the UK Clinical Practice Research Database (CPRD) was analyzed. Researchers looked at information from 145,806 patients who had taken diabetes drugs between the years of 2000 and 2013. Factors like age, gender, smoking status, duration of diabetes, alcohol-related disorders, and other influential factors were considered in the study.
Those who took pioglitazone were found to have an average of 63 percent higher risk of bladder cancer than those not taking a thiazolidinedione drug. The risk of getting bladder cancer while on the diabetes drug seemed to increase with higher doses and longer periods of use.
By contrast, diabetes patients who took rosiglitazone did not show an increase in incidence of bladder cancer. This suggests that the bladder cancer risk is specific to pioglitazone drugs like Actos, and not necessarily associated with the entire class of thiazolidinedione drugs.
Big pharma putting profits over safety?
However, another recent study published in The BMJ looked at diabetes drugs including thiazolidinediones and gliptins in terms of complications and risks versus health rewards. Researchers from the University of Nottingham used the QResearch database to examine data related to 469,688 patients with type 2 diabetes.
Some drugs and combinations drugs taken for diabetes correlated with issues like blindness, kidney failure, high blood sugar, low blood sugar, and amputation. While bladder cancer was only associated with pioglitazone drugs like Actos, this second study calls the entire class of thiazolidinediones and other diabetes drugs into question.
Are diabetes drugs being rushed into consumer use without sufficient testing?
These studies bring even more evidence that the drugs pushed by big pharma should be regarded with suspicion. Whenever possible, proven natural cures should be favored. Healthy diet, lifestyle and supplement choices can help to manage illnesses like diabetes, or prevent them from happening in the first place.

[wow_happens28]

Robert F. Kennedy, Jr. Launches The World Mercury Project

"The Boyz" won't like this, will he be assassinated like his father, uncle, and cousin?

http://www.greenmedinfo.com/blog/robert-f-kennedy-jr-launches-world-mercury-project

Robert F Kennedy Jr. vows to change government policies that injure children.

Washington, DC—Robert F. Kennedy, Jr. announced today the launch of the World Mercury Project (WMP), a public health advocacy organization dedicated to ending exposure to neurotoxic mercury in fish, medical products, dental amalgams and vaccines. The group will focus on making sound science the driver of public policy.

“We will expose the government and corporate corruption that has led to increasing exposures to neurotoxic mercury in foods and medicines,” said Lyn Redwood, RN, MSN, the group’s executive director.

Grassroots organizations who support vaccine choice and autism advocacy, representing thousands of families in the U.S., celebrate the WMP and applaud its actions to ban mercury from all medical products, including vaccines. They stand with WMP to soberly reflect on the 30th anniversary this week of Congress’ enactment of the 1986 National Childhood Vaccine Injury Act (NCVIA), which launched the $32.2 billion yearly vaccine market and some argue indirectly spawned the epidemic of childhood neurological disorders, including autism.

WMP joins these organizations calling for the repeal or radical reform of NCVIA.

“This act provided vaccine manufacturers blanket immunity for any harm caused by injuries from vaccines, no matter how wanton, reckless or negligent the manufacturing, how anemic the testing or how grievous the injury,”
Kennedy said.

“That act and the mountains of pharma cash going to politicians, regulators and the press have helped obliterate all the checks and balances that normally stand between a rapacious industry and vulnerable children in a free and Democratic society. The complete vacuum of accountability caused by the NCVIA has emboldened the worst kind of behavior by vaccine makers including the continued use of mercury in vaccines.”

“We want robust and transparent science, independent and honest regulators, safe vaccines and healthy children,”
Kennedy added.

“Although Congress intended this law to make children healthier and safer, it has paradoxically made them less healthy and less safe, allowing them to receive mercury-contaminated vaccines that other countries have long outlawed.”
Visit our Facts for Media page and www.WORLDMERCURYPROJECT.org to learn more, sign up for free updates, become a member to help our litigation efforts, make a tax-deductible donation and read a list of supporting organizations.

RFK Jr Launches World Mercury Project

For more information on the dangers of mercury poisoning, visit the GreenMedInfo.com Research Dashboard.

[wow_happens28]

Squalene and now Nagalase, which might have got Dr. Bradstreet murdered

https://www.youtube.com/watch?v=b0342N2ZNTI